Cladribine in Multiple Sclerosis: Real-World experience focused on efficacy and safety from Colombia, Latin America

被引：0
作者：
Garcia Bonnito, Juan Raul [1 ]
机构：
[1] Marly Clin, Bogota, Colombia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1579/1576
引用
收藏
页码：1007 / 1007
页数：1
相关论文
共 50 条
[21]   Real-World Fingolimod efficacy and safety in Emirati patients with multiple sclerosis [J].
Ceccarelli, Antonia ;
Mifsud, Victoria ;
Elhennawy, Rawan Yasser Gaber ;
Benedetti, Beatrice ;
Hussain, Syed ;
Samples, Stephen .
NEUROLOGY, 2019, 92 (15)
[22]   Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) [J].
Arena, Sebastiano ;
Chisari, Clara Grazia ;
Toscano, Simona ;
Bucello, Sebastiano ;
Grimaldi, Luigi Maria ;
Ragonese, Paolo ;
Realmuto, Sabrina ;
Cottone, Salvatore ;
Maimone, Davide ;
Finocchiaro, Chiara ;
Reitano, Paola ;
Patti, Francesco .
CURRENT NEUROPHARMACOLOGY, 2024, 22 (07) :1271-1283
[23]   Real-World Outcomes With Cladribine Tablets in People With Relapsing Multiple Sclerosis [J].
Okuda, Darin ;
Livingston, Terrie ;
Moog, Tatum ;
Smith, Alexander ;
Lebson, Lori ;
Piette, Elizabeth .
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 :1100-1100
[24]   Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study [J].
Rolfes, Leoni ;
Pfeuffer, Steffen ;
Huntemann, Niklas ;
Schmidt, Mariella ;
Su, Chuanxin ;
Skuljec, Jelena ;
Aslan, Derya ;
Hackert, Jana ;
Kleinschnitz, Konstanze ;
Hagenacker, Tim ;
Pawlitzki, Marc ;
Ruck, Tobias ;
Kleinschnitz, Christoph ;
Meuth, Sven G. ;
Pul, Refik .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
[25]   Immunological consequences of cladribine treatment in multiple sclerosis: a real-world study [J].
Rolfes, L. ;
Pfeuffer, S. ;
Huntemann, N. ;
Schmidt, M. ;
Su, C. ;
Skuljec, J. ;
Aslan, D. ;
Hackert, J. ;
Kleinschnitz, K. ;
Hagenacker, T. ;
Pawlitzki, M. ;
Ruck, T. ;
Kleinschnitz, C. ;
Meuth, S. G. ;
Pul, R. .
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) :332-333
[26]   Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres [J].
Pfeuffer, Steffen ;
Rolfes, Leoni ;
Hackert, Jana ;
Kleinschnitz, Konstanze ;
Ruck, Tobias ;
Wiendl, Heinz ;
Klotz, Luisa ;
Kleinschnitz, Christoph ;
Meuth, Sven G. ;
Pul, Refik .
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (02) :257-268
[27]   Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers [J].
Conway, Devon S. ;
Nicholas, Jacqueline A. ;
Thompson, Nicolas R. ;
Mowry, Ellen M. ;
Naismith, Robert T. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 94
[28]   Real-world experience switching from high-efficacy infusions to cladribine tablets [J].
Negroski, D. ;
Sellers, D. ;
Khiabani, A. ;
Khiabani, D. .
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) :844-844
[29]   Real-World Experience in an Irish Centre using Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis [J].
O'Donnell, Martin ;
Pavalaghanthan, Hariesh ;
Jose, Shinto ;
Mitten, Ethna ;
Ryan, Aisling .
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 :1000-1001
[30]   Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study [J].
Sorensen, Per Soelberg ;
Pontieri, Luigi ;
Joensen, Hanna ;
Heick, Alex ;
Rasmussen, Peter Vestergaard ;
Schafer, Jakob ;
Ratzer, Rikke ;
Pihl, Caroline Ellinore ;
Sellebjerg, Finn ;
Magyari, Melinda .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
12345